From the Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, NC (Dr. Vanderhave, Dr. Scannell, and Dr. Brighton), and Children's Healthcare of Atlanta, Atlanta, GA (Dr. Perkins).
J Am Acad Orthop Surg. 2018 Feb 1;26(3):94-101. doi: 10.5435/JAAOS-D-16-00255.
Sickle cell disease (SCD) is an autosomal recessive disorder that results in hemolytic anemia related to abnormal hemoglobin and erythrocyte levels. SCD is characterized by vascular occlusive episodes, visceral sequestration, and aplastic or hemolytic crises. These crises most commonly occur in bone. The orthopaedic manifestations of SCD comprise much of the morbidity associated with this disorder. Osteonecrosis and osteomyelitis are among the most disabling and serious musculoskeletal complications in patients with SCD. Effective management of the bone and joint sequelae requires an accurate diagnosis, an understanding of the pathophysiology of the disease, and knowledge of available medical and surgical treatment alternatives. The major orthopaedic manifestations of SCD are osteonecrosis, osteomyelitis, septic arthritis, and bone infarction. Patients with SCD require close monitoring in the perioperative period because of the risk for vasoocclusive crisis.
镰状细胞病(SCD)是一种常染色体隐性遗传病,导致与异常血红蛋白和红细胞水平相关的溶血性贫血。SCD 的特征是血管阻塞发作、内脏隔离和再生不良或溶血性危象。这些危象最常发生在骨骼中。SCD 的矫形表现构成了与这种疾病相关的大部分发病率。骨坏死和骨髓炎是 SCD 患者中最具致残性和最严重的肌肉骨骼并发症之一。有效管理骨骼和关节后遗症需要准确的诊断、对疾病病理生理学的理解以及对可用的医疗和手术治疗选择的了解。SCD 的主要矫形表现为骨坏死、骨髓炎、化脓性关节炎和骨梗死。由于血管阻塞危象的风险,SCD 患者在围手术期需要密切监测。